MetaCap

Envoy Medical (COCH) vs Nutriband (NTRB)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Envoy Medical (COCH) has outperformed Nutriband (NTRB) over the past year, gaining 829.3% versus a gain of 2.9%. Over five years, NTRB leads with a -16.6% price change compared with -31.6% for COCH. Nutriband is the larger company by market cap ($59.8 million vs $51.9 million), about 1.2 times the size, while Envoy Medical is growing revenue faster (+7.1% vs -4.8%).

Nutriband converts more of its revenue into profit, with a net margin of -404.1% versus -9857.3%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

COCH+829.26%NTRB+2.93%
+939%+423%-93%
Nov 21, 20251 yearNov 20, 2026
COCH-31.35%NTRB-9.37%
+91%-6%-104%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

COCH versus NTRB key metrics
MetricCOCHNTRB
Share price$6.70$4.92
Market cap$51.89M$59.81M
1-day change0.00%-1.60%
YTD return+913.62%+8.37%
1-year return+829.26%+2.93%
5-year return-31.56%-16.62%
EPS (TTM)$-4.57$-0.53
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$241.00K$2.04M
Revenue growth (YoY)+7.11%-4.81%
Net income (latest FY)$-23.76M$-8.23M
Gross margin-262.66%27.81%
Operating margin-9240.66%-408.41%
Net margin-9857.26%-404.08%
52-week high$9.54$9.19
52-week low$3.63$2.80
Distance from 52-week high-29.77%-46.43%
Analyst consensusstrong_buynone
Avg. price target upside-67.61%+204.88%
Average volume16.73K70.61K
Shares outstanding7.74M12.16M
Employees43—
SectorHealth CareHealth Care
IndustryIndustrial SpecialtiesIndustrial Specialties

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • COCH has outperformed NTRB by 826.3 percentage points over the past year.
  • Nutriband is more profitable, keeping -404.1 cents of every revenue dollar as net income versus -9857.3 cents for Envoy Medical.
  • Envoy Medical grew revenue faster in its latest fiscal year (+7.11% vs -4.81%).

About Envoy Medical

COCH stock →

Envoy Medical, Inc., a hearing health company, provides medical technologies across the hearing loss spectrum. The company's medical technologies are designed to shift the paradigm within the hearing industry and bring providers and patients the hearing devices desire.

Health Care · Industrial Specialties · 43 employees

About Nutriband

NTRB stock →

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products in the United States.

Health Care · Industrial Specialties

COCH vs NTRB FAQ

Which is bigger, Envoy Medical or Nutriband?

Nutriband (NTRB) is larger, with a market capitalization of $59.81M compared with $51.89M for Envoy Medical (COCH).

Which stock has performed better over the past year, COCH or NTRB?

COCH returned +829.26% over the past 12 months, compared with +2.93% for NTRB (price return, excluding dividends). Past performance does not predict future results.

Are Envoy Medical and Nutriband in the same industry?

Yes. Both are classified in the Industrial Specialties industry within the Health Care sector.

More comparisons